Analysts are seeing that companies and investors are significantly benefiting from the integration of artificial intelligence (AI) across various sectors.

The use of artificial intelligence is increasingly enhancing efficiency, reducing costs and driving innovation.

In some sectors, AI-powered automation streamlines operations and improves customer experiences through personalized recommendations. This leads to increased sales and customer satisfaction.

Investors are seeing substantial returns from companies that effectively integrate AI. Statistics show that companies tend to outperform their peers by leveraging data-driven insights for better decision-making and strategic planning.

Stockhouse recently continued its series of interviews with Austin Zelan, founder of Zelan Consulting and Setter AI.

Watch the full interview in the video above to hear the discussion about how companies are fully integrating the use of AI. It also covers what investors should be looking at to shape their investment strategies with companies using artificial intelligence.

To see more from our AI series with Austin Zelan, head to the rise of autonomous trading systems. As well, check out Enterprises using AI to improve production comes with its challenges.

To stay up to date on all the latest AI and stock market news, head to Stockhouse.com.

Join the discussion: Check out what everyone is saying about artificial intelligence stocks over on Stockhouse’s stock forums and message boards.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.